Typical urine screens detect metabolites from narcotics, stimulants, or alcohol, not complex amino-acid chains like peptides
A phase I safety study in healthy adults confirmed that subcutaneous MOTS-c injections at doses up to 10 mg produced no serious adverse events, with a pharmacokinetic profile supporting once-daily or every-other-day dosing [3]
For research interpretation, the key question is whether the experimental design can distinguish NNMT-mediated effects from broader small-molecule effects
Running a B12 deficitwhich about six percent of Americans under the age of 60and 20 percent of those over 60 do (1)puts you at risk for muscle weakness, fatigue, depression, memory issues, erectile dysfunction, and a cluster of symptoms that can be so severe that theyre debilitating
Regulatory note: Neither peptide is FDA-approved